The German needle-free drug delivery devices market is expected to grow at a CAGR of 12.4% during the forecast period. Germany is one of the key economies of the European region in terms of revenue generation and future opportunity for needle-free drug delivery devices market. The increasing need for self-administration of drugs as in the case of diseases such as diabetes has enhanced the size of needle-free drug delivery devices industry in the UK. Further, as the prevalence of asthma and other diseases increases across Germany, the demand for inhalers is also expected to increase, which in turn, drives the market growth.